Sustained decrease in total T (CD3+) cells, Th (CD4+) cells, Tc (CD8+) cells, and NK (CD16+CD56+) cells was often observed in the current cohort of COVID-19 patients. The gene discussed is NCAM1; the disease is COVID-19.